News
NICE says yes to Novartis' multiple sclerosis therapy Kesimp...
Novartis has secured backing from NICE for its relapsing multiple sclerosis (RMS) therapy Kesimpta in the UK, just two weeks after the drug was approved by the national drugs regulator.
